Different modifying responses of capsaicin in a wide-spectrum initiation model of F344 rat.
- Author:
Ja June JANG
1
;
Kyung Ja CHO
;
Yon Sil LEE
;
Jong Hee BAE
Author Information
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords: Capsaicin; Rat; Carcinogenesis; Multiorgan
- MeSH: Animals; Capsaicin/pharmacology/*toxicity; Cocarcinogenesis; Diethylnitrosamine; Liver Neoplasms, Experimental/chemically induced/prevention & control; Lung Neoplasms/chemically induced/prevention & control; Male; Methylnitrosourea; Neoplasms, Experimental/*chemically induced/prevention & control; Nitrosamines; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms/chemically induced
- From:Journal of Korean Medical Science 1991;6(1):31-36
- CountryRepublic of Korea
- Language:English
- Abstract: The modifying potential of capsaicin (CAP) on lesion development was examined in a rat multiorgan carcinogenesis model. Groups 1 and 2 were treated sequentially with diethylnitrosamine (DEN) (100 mg/kg, ip, single dose at commencement), N-methylnitrosourea (MNU) (20 mg/kg, ip, 4 doses at days 2, 5, 8, and 11), and N,N-dibutylnitrosamine (DBN) (0.05% in drinking water during weeks 3 and 4). Group 3 received vehicles without carcinogens during the initiation period. Group 4 served as the untreated control. After this initiating procedure, Groups 2 and 3 were administered a diet containing 0.01% CAP. All surviving animals were killed 20 weeks after the beginning of the experiment and the target organs examined histopathologically. The induction of GST-P+ hepatic foci in rats treated with carcinogens was significantly inhibited by treatment with CAP. CAP treatment significantly decreased the incidence of adenoma of the lung but increased the incidence of papillary or nodular (PN) hyperplasia of the urinary bladder. The tumor incidence of other organs, such as the kidney and thyroid, was not significantly different from the corresponding controls. These results demonstrated that concurrent treatment with CAP not only can inhibit carcinogenesis but can also enhance it depending on the organ. Thus, this wide-spectrum initiation model could be used to confirm organ-specific modification potential and, in addition, demonstrate different modifying effects of CAP on liver, lung, and bladder carcinogenesis.
